DK1557414T3 - IsoquinoIin-forbindelser og medicinsk anvendelse deraf - Google Patents
IsoquinoIin-forbindelser og medicinsk anvendelse derafInfo
- Publication number
- DK1557414T3 DK1557414T3 DK03748659.4T DK03748659T DK1557414T3 DK 1557414 T3 DK1557414 T3 DK 1557414T3 DK 03748659 T DK03748659 T DK 03748659T DK 1557414 T3 DK1557414 T3 DK 1557414T3
- Authority
- DK
- Denmark
- Prior art keywords
- compound
- cerebral infarction
- agent
- prophylaxis
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002288833 | 2002-10-01 | ||
| JP2002340175 | 2002-11-22 | ||
| JP2003109160 | 2003-04-14 | ||
| PCT/JP2003/012608 WO2004031171A1 (ja) | 2002-10-01 | 2003-10-01 | イソキノリン化合物及びその医薬用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1557414T3 true DK1557414T3 (da) | 2012-05-29 |
Family
ID=32074144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03748659.4T DK1557414T3 (da) | 2002-10-01 | 2003-10-01 | IsoquinoIin-forbindelser og medicinsk anvendelse deraf |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US7220759B2 (da) |
| EP (1) | EP1557414B1 (da) |
| JP (1) | JP4520406B2 (da) |
| KR (1) | KR100735781B1 (da) |
| CN (1) | CN100390164C (da) |
| AT (1) | ATE552252T1 (da) |
| CA (1) | CA2500888C (da) |
| DK (1) | DK1557414T3 (da) |
| ES (1) | ES2380917T3 (da) |
| PT (1) | PT1557414E (da) |
| TW (1) | TW200424188A (da) |
| WO (1) | WO2004031171A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2500888C (en) * | 2002-10-01 | 2010-07-13 | Mitsubishi Pharma Corporation | Isoquinoline compounds and medicinal use thereof |
| ES2376166T3 (es) * | 2002-11-22 | 2012-03-09 | Mitsubishi Tanabe Pharma Corporation | Compuestos de isoquinolina y su uso medicinal. |
| AU2008287831B2 (en) * | 2007-08-10 | 2013-05-23 | Mitsubishi Tanabe Pharma Corporation | Novel salt of isoquinoline compound and crystal thereof |
| TWI499418B (zh) * | 2009-05-21 | 2015-09-11 | Nerviano Medical Sciences Srl | 異喹啉－１（２ｈ）－酮衍生物 |
| JP2014520776A (ja) | 2011-07-04 | 2014-08-25 | バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー | 植物における非生物的ストレスに対する活性薬剤としての置換されているイソキノリノン類、イソキノリンジオン類、イソキノリントリオン類およびジヒドロイソキノリノン類または各場合でのそれらの塩の使用 |
| CN103130723B (zh) | 2011-11-30 | 2015-01-14 | 成都地奥制药集团有限公司 | 一种多聚(adp-核糖)聚合酶抑制剂 |
| US9193689B2 (en) | 2012-03-07 | 2015-11-24 | Institute Of Cancer Research: Royal Cancer Hospital (The) | 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use |
| ES2666729T3 (es) | 2013-09-11 | 2018-05-07 | Institute Of Cancer Research: Royal Cancer Hospital (The) | Compuestos de isoquinolin-1-ona 3-aril-5-sustituida y su uso terapéutico |
| AR098776A1 (es) * | 2013-12-18 | 2016-06-15 | Chiesi Farm Spa | Derivados del isocromeno como inhibidores de las fosfoinositido-3 quinasas |
| BR112022008282A2 (pt) * | 2019-10-30 | 2022-07-26 | Digmbio Inc | Derivados de isoquinolinona, método para preparar os mesmos e composição farmacêutica para prevenir ou tratar doenças relacionadas à poli(adp-ribose) polimerase-1, que compreendem os mesmos como ingrediente ativo |
| CN113636970B (zh) * | 2021-09-13 | 2023-05-23 | 河北康泰药业有限公司 | 一种异吲哚酮的化合物、制备方法及其应用 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1062357A (en) | 1912-05-31 | 1913-05-20 | Warschauer Schrauben Und Drahtfabriken Ag | Nut-lock. |
| US1174272A (en) | 1915-10-27 | 1916-03-07 | Commw Steel | Locomotive-bed. |
| GB1062357A (en) | 1965-03-23 | 1967-03-22 | Pfizer & Co C | Quinazolone derivatives |
| JPS4612454Y1 (da) * | 1968-07-26 | 1971-04-30 | ||
| DE2121031A1 (en) | 1971-04-29 | 1972-11-02 | Dr. Karl Thomae Gmbh, 7950 Biberach | Base-substd quinazolines - thrombocyte aggregation inhibitors |
| IT1054655B (it) | 1975-08-27 | 1981-11-30 | Lepetit Spa | Derivati condensati del l isochinolina |
| JPS52156875A (en) | 1976-06-23 | 1977-12-27 | Mitsui Toatsu Chem Inc | Preparation of novel isoquinolone derivatives |
| JPS5484597A (en) | 1977-12-15 | 1979-07-05 | Yamanouchi Pharmaceut Co Ltd | Novel heterocyclic compound and its preparation |
| JPS6442472U (da) | 1986-06-14 | 1989-03-14 | ||
| US4808595A (en) | 1986-12-24 | 1989-02-28 | Merck & Co., Inc. | Furopyridine sulfonamides and their opthalmological compositions |
| JPS6442472A (en) | 1987-08-10 | 1989-02-14 | Kanebo Ltd | Quinazoline derivative, production thereof and brain function disorder improving agent containing said derivative as active ingredient |
| DE68920798T2 (de) | 1988-08-19 | 1995-05-18 | Warner Lambert Co | Substituierte Dihydroisochinolinone und verwandte Verbindungen als Verstärker der letalen Effekte von Bestrahlung und bestimmten Chemotherapeutika; ausgewählte Verbindungen, Analoga und Verfahren. |
| WO1999008680A1 (en) | 1997-08-15 | 1999-02-25 | The Johns Hopkins University | Method of using selective parp inhibitors to prevent or treat neurotoxicity |
| US6514983B1 (en) | 1997-09-03 | 2003-02-04 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| US6635642B1 (en) | 1997-09-03 | 2003-10-21 | Guilford Pharmaceuticals Inc. | PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same |
| US6197785B1 (en) * | 1997-09-03 | 2001-03-06 | Guilford Pharmaceuticals Inc. | Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity |
| US20020022636A1 (en) * | 1997-09-03 | 2002-02-21 | Jia-He Li | Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| AU9297998A (en) * | 1998-05-15 | 1999-12-06 | Guilford Pharmaceuticals Inc. | Carboxamide compounds, compositions, and methods for inhibiting parp activity |
| WO2000042025A1 (fr) | 1999-01-14 | 2000-07-20 | Meiji Seika Kaisha, Ltd. | Inhibiteurs de poly(adp-ribose) polymerase consistant en des derives de pyrimidine |
| AU3076700A (en) | 1999-01-26 | 2000-08-18 | Ono Pharmaceutical Co. Ltd. | 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient |
| DE19918211A1 (de) | 1999-04-22 | 2000-10-26 | Basf Ag | Cycloalkylsubstituierte Benzimidazole, deren Herstellung und Anwendung |
| DE19920936A1 (de) | 1999-05-07 | 2000-11-09 | Basf Ag | Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung |
| DE19921567A1 (de) | 1999-05-11 | 2000-11-16 | Basf Ag | Verwendung von Phthalazine-Derivaten |
| WO2001079184A1 (fr) | 2000-04-18 | 2001-10-25 | Sumitomo Pharmaceuticals Company, Limited | Composes de piperazine substitues |
| AU2002220241A1 (en) | 2000-12-01 | 2002-06-11 | Iconix Pharmaceuticals, Inc. | Parb inhibitors |
| AUPR201600A0 (en) | 2000-12-11 | 2001-01-11 | Fujisawa Pharmaceutical Co., Ltd. | Quinazolinone derivative |
| CA2444531A1 (en) | 2001-05-08 | 2002-11-14 | Kudos Pharmaceuticals Limited | Isoquinolinone derivatives as parp inhibitors |
| JPWO2002094790A1 (ja) | 2001-05-23 | 2004-09-09 | 三菱ウェルファーマ株式会社 | 縮合ヘテロ環化合物およびその医薬用途 |
| AUPS019702A0 (en) | 2002-01-29 | 2002-02-21 | Fujisawa Pharmaceutical Co., Ltd. | Condensed heterocyclic compounds |
| CA2500888C (en) * | 2002-10-01 | 2010-07-13 | Mitsubishi Pharma Corporation | Isoquinoline compounds and medicinal use thereof |
| ES2376166T3 (es) | 2002-11-22 | 2012-03-09 | Mitsubishi Tanabe Pharma Corporation | Compuestos de isoquinolina y su uso medicinal. |
| JP4612454B2 (ja) | 2005-03-31 | 2011-01-12 | 本田技研工業株式会社 | ブレーキ制御装置 |
-
2003
- 2003-10-01 CA CA2500888A patent/CA2500888C/en not_active Expired - Fee Related
- 2003-10-01 EP EP03748659A patent/EP1557414B1/en not_active Expired - Lifetime
- 2003-10-01 DK DK03748659.4T patent/DK1557414T3/da active
- 2003-10-01 JP JP2005500092A patent/JP4520406B2/ja not_active Expired - Fee Related
- 2003-10-01 CN CNB200380100827XA patent/CN100390164C/zh not_active Expired - Fee Related
- 2003-10-01 WO PCT/JP2003/012608 patent/WO2004031171A1/ja active IP Right Grant
- 2003-10-01 TW TW092127338A patent/TW200424188A/zh not_active IP Right Cessation
- 2003-10-01 ES ES03748659T patent/ES2380917T3/es not_active Expired - Lifetime
- 2003-10-01 KR KR1020057005596A patent/KR100735781B1/ko active IP Right Grant
- 2003-10-01 AT AT03748659T patent/ATE552252T1/de active
- 2003-10-01 PT PT03748659T patent/PT1557414E/pt unknown
-
2004
- 2004-04-30 US US10/836,377 patent/US7220759B2/en active Active
-
2007
- 2007-03-19 US US11/688,103 patent/US7459465B2/en not_active Expired - Lifetime
-
2008
- 2008-11-03 US US12/263,963 patent/US7812178B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20070161620A1 (en) | 2007-07-12 |
| JPWO2004031171A1 (ja) | 2006-02-02 |
| CA2500888A1 (en) | 2004-04-15 |
| PT1557414E (pt) | 2012-04-17 |
| TW200424188A (en) | 2004-11-16 |
| CN1703410A (zh) | 2005-11-30 |
| KR100735781B1 (ko) | 2007-07-06 |
| ES2380917T3 (es) | 2012-05-21 |
| US7812178B2 (en) | 2010-10-12 |
| ATE552252T1 (de) | 2012-04-15 |
| CN100390164C (zh) | 2008-05-28 |
| US20040248931A1 (en) | 2004-12-09 |
| JP4520406B2 (ja) | 2010-08-04 |
| AU2003268724A1 (en) | 2004-04-23 |
| CA2500888C (en) | 2010-07-13 |
| TWI338687B (da) | 2011-03-11 |
| WO2004031171A1 (ja) | 2004-04-15 |
| US7459465B2 (en) | 2008-12-02 |
| EP1557414A4 (en) | 2007-10-31 |
| EP1557414A1 (en) | 2005-07-27 |
| US20090076276A1 (en) | 2009-03-19 |
| KR20050070024A (ko) | 2005-07-05 |
| EP1557414B1 (en) | 2012-04-04 |
| US7220759B2 (en) | 2007-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1566380A4 (en) | ISOQUINOLINONE COMPOUNDS AND THEIR USE FOR MEDICINAL PURPOSES | |
| IL171977A0 (en) | Cyclic sulfonamides for inhibition of gamma-secretase | |
| AU5584901A (en) | Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease | |
| MXPA04000793A (es) | Novedoso metodo terapeutico. | |
| GB0318447D0 (en) | Therapeutic agents | |
| MXPA05008172A (es) | Derivados de malonamida como inhibidores gamma-secretasa. | |
| GB0225475D0 (en) | Therapeutic agents | |
| NO2007010I1 (no) | Sitagliptin, eventuelt i form av et farmasoytisk akseptabelt salt | |
| EA200200306A1 (ru) | Трициклические ингибиторы поли(адф-рибозо)полимераз | |
| TNSN04165A1 (en) | Substituted hydroxyethylamines | |
| MXPA04004370A (es) | Derivados policiclicos de guanina inhibidores de fosfodiesterasa v. | |
| IL179634A0 (en) | 5-substituted-2-phenylamino-benzamides as mek inhibitor | |
| CA2341031A1 (en) | Novel salt form of pantoprazole | |
| SE0104332D0 (sv) | Therapeutic agents | |
| EP1562897A4 (en) | PHENYL ACARBOXAMIDE AS A BETA SEKRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER | |
| NO20063275L (no) | Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom | |
| ECSP055844A (es) | Nuevos compuestos triciclicos | |
| ATE535236T1 (de) | Therapeutische strategien für die prävention und behandlung der alzheimer-krankheit | |
| HK1086011A1 (en) | Ccr1 antagonists for the treatment of i.a demyelinating inflammatory disease | |
| SE0202429D0 (sv) | Novel Compounds | |
| MXPA04006031A (es) | Compuestos para el tratamiento de trastornos inflamatorios. | |
| DK1557414T3 (da) | IsoquinoIin-forbindelser og medicinsk anvendelse deraf | |
| WO2002051832A3 (en) | Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands | |
| UY26851A1 (es) | Derivados de la 4-fenilpiridina | |
| ATE357453T1 (de) | Comt-inhibitoren |